EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Temporal associations of plasma levels of the secreted phospholipase A 2 family and mortality in severe COVID‐19

Eric Lu iD, Aki Hara iD, Shudong Sun, Brian Hallmark, Justin M Snider, Michael C Seeds, Joseph C Watkins, Charles E McCall, Hao Helen Zhang, Guang Yao, Floyd H Chilton

European Journal of Immunology · 2024

DOI: 10.1002/eji.202350721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Eric Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, Agricultural Research Service, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous research suggests that group IIA‐secreted phospholipase A 2 (sPLA 2 ‐IIA) plays a role in and predicts lethal COVID‐19 disease. The current study reanalyzed a longitudinal proteomic data set to determine the temporal relationship between levels of several members of a family of sPLA 2 isoforms and the severity of COVID‐19 in 214 ICU patients. The levels of six secreted PLA 2 isoforms, sPLA 2 ‐IIA, sPLA 2 ‐V, sPLA 2 ‐X, sPLA 2 ‐IB, sPLA 2 ‐IIC, and sPLA 2 ‐XVI, increased over the first 7 ICU days in those who succumbed to the disease but attenuated over the same time period in survivors. In contrast, a reversed pattern in sPLA 2 ‐IID and sPLA 2 ‐XIIB levels over 7 days suggests a protective role of these two isoforms. Furthermore, decision tree models demonstrated that sPLA 2 ‐IIA outperformed top‐ranked cytokines and chemokines as a predictor of patient outcome. Taken together, proteomic analysis revealed temporal sPLA 2 patterns that reflect the critical roles of sPLA 2 isoforms in severe COVID‐19 disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansFemaleMaleMiddle AgedAgedPhospholipases A2, SecretoryProteomicsSeverity of Illness IndexGroup II Phospholipases A2AdultProtein IsoformsCytokines

Stichwörter der Autor:innen

COVID‐19ProteomicssPLA2

Substanzen

Phospholipases A2, SecretoryGroup II Phospholipases A2Protein IsoformsCytokines

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.
  • School of Nutritional Sciences and Wellness, College of Agriculture and Life Sciences, University of Arizona, Tucson, Arizona, USA.
  • Department of Mathematics, University of Arizona, Tucson, Arizona, USA.
  • Statistics Interdisciplinary Program, University of Arizona, Tucson, Arizona, USA.
  • BIO5 Institute, University of Arizona, Tucson, Arizona, USA.
  • Arizona Cancer Center, University of Arizona, Tucson, Arizona, USA.

ORCID-Profile: Eric Lu, Aki Hara

Förderung

  • NIH HHS
  • Agricultural Research Service
  • National Institutes of Health

Zitieren

APA

Lu, E., Hara, A., Sun, S., Hallmark, B., Snider, J. M., Seeds, M. C., Watkins, J. C., McCall, C. E., Zhang, H. H., Yao, G., & Chilton, F. H. (2024). Temporal associations of plasma levels of the secreted phospholipase A 2 family and mortality in severe COVID‐19. European Journal of Immunology. https://doi.org/10.1002/eji.202350721

Vancouver

Lu E, Hara A, Sun S, Hallmark B, Snider JM, Seeds MC, et al. Temporal associations of plasma levels of the secreted phospholipase A 2 family and mortality in severe COVID‐19. European Journal of Immunology. 2024. doi:10.1002/eji.202350721

BibTeX
@article{Lu2024,
  author = {Lu, Eric and Hara, Aki and Sun, Shudong and Hallmark, Brian and Snider, Justin M and Seeds, Michael C and Watkins, Joseph C and McCall, Charles E and Zhang, Hao Helen and Yao, Guang and Chilton, Floyd H},
  title = {Temporal associations of plasma levels of the secreted phospholipase A 2 family and mortality in severe COVID‐19},
  journal = {European Journal of Immunology},
  year = {2024},
  doi = {10.1002/eji.202350721}
}
Kostenlos starten →